| P50 | author | Kyoung-Mee Kim | Q88377030 |
| P2093 | author name string | Se Hoon Park | |
| | Sung Kim | |
| | Jeeyun Lee | |
| | Seung Tae Kim | |
| | Won Ki Kang | |
| | Joon Ho Lee | |
| | Ji Yeong An | |
| | Jae Moon Bae | |
| | Min Gew Choi | |
| | Tae Sung Sohn | |
| | Heejin Bang | |
| | Junhun Cho | |
| P2860 | cites work | Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer | Q24685406 |
| | PD-L1 is an independent prognostic predictor in gastric cancer of Western patients | Q27853364 |
| | Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion | Q27860475 |
| | The blockade of immune checkpoints in cancer immunotherapy | Q27860852 |
| | PD-L1 and Survival in Solid Tumors: A Meta-Analysis | Q28084090 |
| | Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction | Q28215716 |
| | PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells | Q28243975 |
| | Comprehensive molecular characterization of gastric adenocarcinoma | Q28244985 |
| | Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer | Q28245751 |
| | Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion | Q28281101 |
| | Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients | Q29617771 |
| | Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape | Q29620881 |
| | Upregulation of circulating PD-L1/PD-1 is associated with poor post-cryoablation prognosis in patients with HBV-related hepatocellular carcinoma | Q34017748 |
| | Programmed death ligand-1 expression in non-small cell lung cancer | Q34384255 |
| | Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial | Q34634440 |
| | The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints | Q34943776 |
| | Gastric cancer epidemiology and risk factors | Q35067625 |
| | Nanostring-based multigene assay to predict recurrence for gastric cancer patients after surgery | Q35112054 |
| | Upregulation of PD-L1 and APE1 is associated with tumorigenesis and poor prognosis of gastric cancer | Q35113261 |
| | Development of an automated PD-L1 immunohistochemistry (IHC) assay for non-small cell lung cancer | Q36032963 |
| | Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up. | Q36439488 |
| | Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer | Q36608731 |
| | The prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patients | Q36946671 |
| | Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer | Q36977523 |
| | Immune checkpoints programmed death 1 ligand 1 and cytotoxic T lymphocyte associated molecule 4 in gastric adenocarcinoma. | Q37012537 |
| | Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers | Q37362803 |
| | PD-L1 expression in the Merkel cell carcinoma microenvironment: association with inflammation, Merkel cell polyomavirus and overall survival | Q37454288 |
| | Is microsatellite instability a prognostic marker in gastric cancer? A systematic review with meta-analysis. | Q38204955 |
| | Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial | Q38829062 |
| | PD-L1 expression is associated with massive lymphocyte infiltration and histology in gastric cancer | Q38858292 |
| | Prognostic role of PD-L1 in malignant solid tumors: a meta-analysis | Q38911904 |
| | In situ tumor PD-L1 mRNA expression is associated with increased TILs and better outcome in breast carcinomas | Q39013804 |
| | Programmed cell death-ligand 1 expression in surgically resected stage I pulmonary adenocarcinoma and its correlation with driver mutations and clinical outcomes. | Q39248696 |
| | Overall survival and PD-L1 expression in metastasized malignant melanoma | Q39756798 |
| | PD-L1 expression analysis in gastric carcinoma tissue and blocking of tumor-associated PD-L1 signaling by two functional monoclonal antibodies | Q40185070 |
| | Programmed Death-Ligand 1 Expression Is Common in Gastric Cancer Associated With Epstein-Barr Virus or Microsatellite Instability | Q40503160 |
| | Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. | Q41038524 |
| | Epstein-Barr virus infection serves as an independent predictor of survival in patients with lymphoepithelioma-like gastric carcinoma | Q41057521 |
| | Programmed cell death protein 1 expression is an independent prognostic factor in gastric cancer after curative resection | Q41547569 |
| | Targeting PD-1/PD-L1 interactions for cancer immunotherapy | Q41817131 |
| | PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies | Q41826795 |
| | Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma | Q45054030 |
| | Host inflammatory response predicts survival of patients with Epstein-Barr virus-associated gastric carcinoma | Q45376744 |
| | Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer. | Q50963140 |
| | Microsatellite instability in sporadic gastric cancer: its prognostic role and guidance for 5-FU based chemotherapy after R0 resection. | Q51417165 |
| | High microsatellite instability predicts good prognosis in intestinal-type gastric cancers. | Q51503013 |
| | Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer. | Q53249720 |
| | Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer. | Q54287306 |
| | Gastric cancer | Q57758203 |
| | Microsatellite instability at multiple loci in gastric carcinoma: Clinicopathologic implications and prognosis | Q61627303 |
| | Incidence and factors associated with recurrence patterns after intended curative surgery for gastric cancer | Q73077224 |
| | Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers | Q79448724 |
| | Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance | Q82793374 |
| | Correlation between infiltration of FOXP3+ regulatory T cells and expression of B7-H1 in the tumor tissues of gastric cancer | Q87494688 |
| | Expression of costimulatory molecules B7-H1, B7-H4 and Foxp3+ Tregs in gastric cancer and its clinical significance | Q87827796 |
| | Dual Faces of IFNγ in Cancer Progression: A Role of PD-L1 Induction in the Determination of Pro- and Antitumor Immunity | Q89066168 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microsatellite | Q265193 |
| | cell death | Q2383867 |
| P304 | page(s) | 13320-13328 | |
| P577 | publication date | 2017-01-05 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Programmed cell death-ligand 1 expression predicts survival in patients with gastric carcinoma with microsatellite instability | |
| P478 | volume | 8 | |